相关实验视频
Updated: Jun 17, 2025
13:28
Methodology for Sputum Induction and Laboratory Processing
Published on: December 17, 2017
27.5K
梅波利祖马布可以减轻炎症,但在严重的喘中可以保持恒常性乙氨基酸细胞的存在
Michael Fricker1,2, John Harrington2,3, Sarah A Hiles2,4
1School of Medicine and Public Health, University of Newcastle, Newcastle, New South Wales, Australia.
Allergy
|August 8, 2024
概括
梅波利祖马布和本拉利祖马布在严重喘中降低炎症性乙氨基酸细胞. 梅波利祖马布可以保持恒常性乙氨基酸,并降低乙氨基酸的活力,与更好的喘控制相关.
科学领域:
- 免疫学 免疫学 免疫学
- 呼吸系统医学 呼吸系统医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 严重的喘是IL5生物药物如美波利祖马布和本拉利祖马布的目标.
- 这些疗法对恒常性 (hEOs) 和炎性 (iEOs) 乙酸氨基基基团子集的影响尚不清楚.
- 了解乙酸氨基基基组动态对于优化严重喘治疗至关重要.
研究的目的:
- 为了比较梅波利祖马布和本拉利祖马布在严重喘中对乙氨基子子集 (hEOs,iEOs) 和表型的影响.
- 为了研究乙氨基基基子集与临床特征之间的关联,包括治疗反应.
主要方法:
- 严重喘患者的横截面和纵向观察研究.
- 使用流细胞计 (CD62L蛋白表达) 测量血液HEOs和IEOs.
- 在接受梅波利祖马布和本拉利祖马布治疗组中分析治疗效应.
主要成果:
- 梅波利祖马布和本拉利祖马布都减少了IEOs,但梅波利祖马布保留了HEOs.
- 较高的IEO比例与埃索诺菲尔性喘中较差的喘控制相关.
- 在接受梅波利祖马布治疗的患者中,乙氨基酸活性的降低与更好的喘控制和精神计量有关.
结论:
- 梅波利祖马布消耗IEOs,降低埃索诺菲尔活力,并在严重喘中保持HEOs.
- 本拉利祖马布减少了IEO和HEO的使用.
- 循环中的乙氨基基基表型和活力可以预测严重喘时对生物治疗的反应.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
261
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
261
01:24Antiasthma Drugs: Methylxanthines
213
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
213
01:19Antiasthma Drugs: Leukotriene Modifiers
267
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
267
01:17Drugs Used in Lower Respiratory Disorders: Overview
383
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
383
01:26Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
01:20Asthma: Pathogenesis and Management
378
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
378